Skip to main content

Adaptimmune Therapeutics plc (ADAP)

NASDAQ: ADAP · IEX Real-Time Price · USD
0.793
+0.103 (14.91%)
At close: Dec 29, 2023, 4:00 PM
0.790
-0.003 (-0.38%)
After-hours: Dec 29, 2023, 7:55 PM EST

Adaptimmune Therapeutics Market Cap

Adaptimmune Therapeutics has a market cap or net worth of $156.61 million as of December 29, 2023. Its market cap has decreased by -32.70% in one year.

Market Cap
156.61M
Enterprise Value
17.47M
1-Year Change
-32.70%
Ranking
#3839
Category
Micro-Cap
Stock Price
$0.79

Market Cap Chart

Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $156.61M, a decrease of -72.79%. That is a compound annual growth rate of -15.46%.

History

DateMarket Cap% Change
Dec 29, 2023180.10M
14.93%
Dec 28, 2023156.70M
-4.04%
Dec 27, 2023163.30M
23.06%
Dec 26, 2023132.70M
16.81%
Dec 22, 2023113.60M
5.67%
Dec 21, 2023107.50M
7.29%
Dec 20, 2023100.20M
-4.11%
Dec 19, 2023104.50M
2.25%
Dec 18, 2023102.20M-
Dec 15, 2023102.20M
-7.84%
Dec 14, 2023110.90M
-4.07%
Dec 13, 2023115.60M
2.85%
Dec 12, 2023112.40M
-1.40%
Dec 11, 2023114.00M
-7.92%
Dec 8, 2023123.80M
-4.40%
Dec 7, 2023129.50M
1.65%
Dec 6, 2023127.40M-
Dec 5, 2023127.40M
5.99%
Dec 4, 2023120.20M
-2.36%
Dec 1, 2023123.10M
8.36%
Nov 30, 2023113.60M
0.44%
Nov 29, 2023113.10M
11.65%
Nov 28, 2023101.30M
-6.12%
Nov 27, 2023107.90M
2.18%
Nov 24, 2023105.60M
3.53%
View and export this data all the way back to 2016. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Kodiak Sciences 159.52M
Molecular Partners AG 159.30M
PMV Pharmaceuticals 158.59M
G1 Therapeutics 158.12M
I-Mab 156.98M
PDS Biotechnology 154.61M
Dianthus Therapeutics 154.11M
Vor Biopharma 152.56M
Market Cap Rankings